Skip to main content

Cell MedX Corp (CMXC)

OTCMKTS: CMXC · Delayed Price · USD
0.2247 0.0247 (12.35%)
Sep 15, 2021 3:33 PM EDT - Market closed

Income Statement (Annual)

Financials in millions USD. Fiscal year is June - May.
Year2020201920182017201620152014201320122011
Revenue
0.1000.010.040.040000
Revenue Growth
----82.99%-14.23%-----
Cost of Revenue
0.010000.030.030000
Gross Profit
0.090000.010.020000
Selling, General & Admin
0.450.140.240.40.240.290.020.010.020.01
Research & Development
0.390.260.420.30.650.180000
Other Operating Expenses
0.280.260.880.531.220.480000
Operating Expenses
1.120.671.541.222.110.950.020.010.020.01
Operating Income
-1.04-0.67-1.54-1.22-2.1-0.94-0.02-0.01-0.02-0.01
Interest Expense / Income
0.020.020.010.030.030.010000
Other Expense / Income
0.030.220000.090000
Pretax Income
-1.09-0.91-1.55-1.25-2.14-1.03-0.02-0.01-0.02-0.01
Net Income
-1.09-0.91-1.55-1.25-2.14-1.03-0.02-0.01-0.02-0.01
Net Income Common
-1.09-0.91-1.55-1.25-2.14-1.03-0.02-0.01-0.02-0.01
Shares Outstanding (Basic)
53444237313131313030
Shares Outstanding (Diluted)
53444237313131313030
Shares Change
20.76%4.66%14.79%18.90%0.00%0.00%0.00%2.40%0.91%-
EPS (Basic)
-0.02-0.02-0.04-0.03-0.07-0.03----
EPS (Diluted)
-0.02-0.02-0.04-0.03-0.07-0.03----
Free Cash Flow Per Share
-0.02-0.01-0.01-0.02-0.02-0.01---0.00-0.00
Gross Margin
89.32%--34.87%22.27%37.69%----
Operating Margin
-1083.60%---19619.87%-5756.09%-2198.41%----
Profit Margin
-1140.32%---20087.56%-5851.51%-2421.56%----
Free Cash Flow Margin
-968.76%---13895.39%-1751.68%-808.49%----
EBITDA
-1.07-0.89-1.54-1.1-2.09-1.02-0.02-0.01-0.02-0.01
EBITDA Margin
-1116.40%---17642.09%-5705.33%-2402.39%----
EBIT
-1.07-0.89-1.54-1.22-2.11-1.03-0.02-0.01-0.02-0.01
EBIT Margin
-1118.33%---19620.32%-5761.69%-2406.98%----